{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":14,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":14,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"b440a9f20b63","filters":{"venue":"Generics and Biosimilars Initiative Journal"}},"results":[{"id":"W2320750953","doi":"10.5639/gabij.2014.0303.033","title":"Subsequent entry biologics (biosimilars) in Canada: approaches to interchangeability and the extrapolation of indications and uses","year":2014,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Canada","funders":"","keywords":"Biosimilar; Interchangeability; Extrapolation; Business; Medicine; Computer science; Mathematics; Internal medicine","authors":[{"name":"Ágnes Klein","is_ca":true},{"name":"Jian Wang","is_ca":true},{"name":"Patrick Bedford","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1409382763221571,"gpt":0.2574729309045367,"spread":0.1165346545823797,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05608427,0.0009801334,0.001156236,0.00828206,0.00745676,0.01640573,0.005218816,0.005123756,0.003828552],"category_scores_gemma":[0.1111573,0.001243579,0.002274717,0.006647883,0.01695126,0.006890075,0.006436056,0.01400031,0.0007193513],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08859213,"about_ca_system_score_gemma":0.2201122,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9307001,"about_ca_topic_score_gemma":0.929262,"domain_scores_codex":[0.9383691,0.01372901,0.004423173,0.004263258,0.03569641,0.003519114],"domain_scores_gemma":[0.8827066,0.03782088,0.008608777,0.007449576,0.05983797,0.003576121],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002688346,0.0001068082,0.01333872,0.0008728751,0.0001070736,0.000808605,0.01027324,0.003001882,0.001514064,0.727787,0.04182918,0.2000917],"study_design_scores_gemma":[0.0001243445,0.0003541067,0.04320036,0.005850088,0.0003184607,0.001282805,0.007126111,0.007234767,0.005719573,0.2005401,0.7277995,0.0004497814],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.04486004,0.04195291,0.2145016,0.2566252,0.002959707,0.002072057,0.005016223,0.001312057,0.4307002],"genre_scores_gemma":[0.5483447,0.03154687,0.273787,0.08242198,0.001101781,0.0008369469,0.002482184,0.0006723621,0.05880633],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.9114079,"threshold_uncertainty_score":0.6427839,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4229584754","doi":"10.5639/gabij.2014.0401.012","title":"Comparison of biosimilars guidelines","year":2014,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Medicine; Internal medicine","authors":[{"name":"GaBI Journal Editor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1402436365381827,"gpt":0.4017053913739141,"spread":0.2614617548357314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02184612,0.0003483655,0.0007108793,0.01047584,0.0009775236,0.003897889,0.001159909,0.00269657,0.004434972],"category_scores_gemma":[0.1016272,0.0003145999,0.001266379,0.008150152,0.0009406848,0.001488692,0.001625616,0.002310931,0.001120952],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005733154,"about_ca_system_score_gemma":0.01321176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01297608,"about_ca_topic_score_gemma":0.01240233,"domain_scores_codex":[0.9463373,0.01178015,0.01009913,0.001615864,0.02837744,0.001790049],"domain_scores_gemma":[0.8950934,0.0314604,0.008797698,0.00385183,0.05864995,0.002146706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002396356,0.0006992721,0.02765796,0.00977766,0.0006851972,0.001110436,0.003426146,0.005182916,0.01063743,0.1260848,0.1578772,0.6544646],"study_design_scores_gemma":[0.000352199,0.0007835051,0.05339617,0.0061022,0.0005554243,0.001342361,0.002180174,0.001130134,0.007160973,0.01327593,0.9135807,0.0001401367],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.2359878,0.1325829,0.03629557,0.04337719,0.005559584,0.003509204,0.02446523,0.001572943,0.5166495],"genre_scores_gemma":[0.7577837,0.06491958,0.06842047,0.04534752,0.001400415,0.002027374,0.03740557,0.000929339,0.02176616],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02184612,"threshold_uncertainty_score":0.1155347,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2326320320","doi":"10.5639/gabij.2015.0401.009","title":"Health Canada’s perspective on the clinical development of biosimilars and related scientific and regulatory challenges","year":2015,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Canada","funders":"","keywords":"Biosimilar; Perspective (graphical); Regulatory science; Business; Medicine; Computer science; Internal medicine; Pathology","authors":[{"name":"Ally Pen","is_ca":true},{"name":"Ágnes Klein","is_ca":true},{"name":"Jian Wang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1566998178822719,"gpt":0.3526119372573578,"spread":0.1959121193750858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03016249,0.001628223,0.001573021,0.003171314,0.008802048,0.01676455,0.005474898,0.05458808,0.01817097],"category_scores_gemma":[0.04000309,0.000871756,0.003160267,0.003857422,0.01376478,0.006812857,0.004658122,0.02679239,0.002379684],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08222409,"about_ca_system_score_gemma":0.4000431,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.8706622,"about_ca_topic_score_gemma":0.9070734,"domain_scores_codex":[0.9651853,0.006227269,0.001448608,0.002297469,0.0178292,0.007012188],"domain_scores_gemma":[0.9124854,0.01779922,0.002511688,0.001239514,0.04049156,0.02547259],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0001429258,0.0001094641,0.001055909,0.0004863862,0.00006111273,0.0008670548,0.0003807434,0.0008891859,0.0007586952,0.108253,0.8481453,0.03885017],"study_design_scores_gemma":[0.000124142,0.0001221371,0.00204031,0.0008106948,0.00006052092,0.0004481678,0.0007408948,0.000640646,0.0002463318,0.02007462,0.9745657,0.0001257948],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0003758352,0.01322301,0.0003613193,0.9683099,0.004682786,0.00002396981,0.0001519631,0.00003130573,0.01283989],"genre_scores_gemma":[0.02230379,0.0323737,0.003272908,0.9164972,0.008452927,0.00004562907,0.0002478013,0.00006000431,0.0167461],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.9698375,"threshold_uncertainty_score":0.5965804,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3119789362","doi":"10.5639/gabij.2021.1002.008","title":"Variation in the prices of oncology medicines across Europe and the implications for the future","year":2021,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadiana.org","funders":"","keywords":"Reimbursement; Population; Medicine; Per capita; Gross domestic product; Erlotinib; Life expectancy; Health care; Economics; Cancer; Internal medicine; Economic growth; Environmental health","authors":[{"name":"Brian Godman","is_ca":false},{"name":"Steven Simoens","is_ca":false},{"name":"Amanj Kurdi","is_ca":false},{"name":"Gisbert Selke","is_ca":false},{"name":"John Yfantopoulos","is_ca":false},{"name":"Andrew Hill","is_ca":false},{"name":"Jolanta Gulbinovič","is_ca":false},{"name":"Antony P. Martin","is_ca":false},{"name":"Angela Timoney","is_ca":false},{"name":"Dzintars Gotham","is_ca":false},{"name":"Janet Wale","is_ca":false},{"name":"Tomasz Bochenek","is_ca":false},{"name":"Iva Selke Krulichová","is_ca":false},{"name":"Eleonora Allocati","is_ca":false},{"name":"Iris Hoxha","is_ca":false},{"name":"Admir Malaj","is_ca":false},{"name":"A. Nachtnebel","is_ca":false},{"name":"Wouter Hamelinck","is_ca":false},{"name":"Zornitza Mitkova","is_ca":false},{"name":"Guenka Petrova","is_ca":false},{"name":"Ott Laius","is_ca":false},{"name":"Catherine Sermet","is_ca":false},{"name":"Irene Langner","is_ca":false},{"name":"Roberta Joppi","is_ca":false},{"name":"Elita Poplavska","is_ca":false},{"name":"Ieva Greičiūtė-Kuprijanov","is_ca":false},{"name":"Patricia Vella Bonanno","is_ca":false},{"name":"JF Hans Piepenbrink","is_ca":false},{"name":"Vincent de Valk","is_ca":false},{"name":"Robert Plisko","is_ca":false},{"name":"Magdałene Władysiuk","is_ca":false},{"name":"Vanda Marković‐Peković","is_ca":false},{"name":"Ileana Mardare","is_ca":false},{"name":"Tanja Novaković","is_ca":false},{"name":"Mark Parker","is_ca":false},{"name":"Jurij Fürst","is_ca":false},{"name":"D Tomek","is_ca":false},{"name":"Katarína Baňasová","is_ca":false},{"name":"Mercè Obach Cortadellas","is_ca":false},{"name":"Corrine Zara","is_ca":false},{"name":"Caridad Pontes","is_ca":false},{"name":"Maria Juhasz-Haverinen","is_ca":false},{"name":"Peter Skiöld","is_ca":false},{"name":"Stuart McTaggart","is_ca":false},{"name":"Durhane Wong‐Rieger","is_ca":false},{"name":"Stephen Campbell","is_ca":true},{"name":"Ruaraidh Hill","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05162742510960357,"gpt":0.3045067771538137,"spread":0.2528793520442102,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003126428,0.0001303439,0.0003397859,0.001239822,0.0001818114,0.00178653,0.0003794325,0.0004747253,0.002335143],"category_scores_gemma":[0.01157351,0.0001274463,0.0007383445,0.003161971,0.000489323,0.001444054,0.0006015277,0.0005260896,0.0001894035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001167915,"about_ca_system_score_gemma":0.0007446762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004674274,"about_ca_topic_score_gemma":0.003051161,"domain_scores_codex":[0.9984152,0.0004464803,0.0002602688,0.0003834981,0.0003807802,0.000113756],"domain_scores_gemma":[0.9929299,0.00277134,0.002892275,0.0002801404,0.0008857401,0.0002406648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000774512,0.0000821744,0.8006397,0.001552134,0.00146318,0.001620864,0.001603489,0.005259543,0.001098088,0.01922099,0.01044162,0.1562437],"study_design_scores_gemma":[0.00001686571,0.00007689804,0.972765,0.0004941884,0.0001704413,0.001012148,0.001224672,0.0010728,0.0003583197,0.003353067,0.01941414,0.00004148259],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9281012,0.04046268,0.002293415,0.009511175,0.0002588136,0.00002873861,0.005613212,0.00002604392,0.01370473],"genre_scores_gemma":[0.9908812,0.005768296,0.0008507782,0.0006368805,0.00009249177,0.000009788453,0.001363363,0.00001412918,0.0003832467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004674274,"threshold_uncertainty_score":0.01653433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2493092156","doi":"10.5639/gabij.2016.0502.014","title":"Adjusted indirect comparisons between generics – bioequivalence and interchangeability","year":2016,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Interchangeability; Bioequivalence; Medicine; Pharmacology; Computer science; Pharmacokinetics","authors":[{"name":"László Endrényi","is_ca":true},{"name":"László Tóthfalusi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2569267108682741,"gpt":0.3146563185770117,"spread":0.05772960770873753,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07638894,0.001588145,0.002666285,0.002738937,0.0007455088,0.00402266,0.002192369,0.001603838,0.029017],"category_scores_gemma":[0.3064476,0.0005253307,0.006445338,0.004711513,0.002004971,0.005167329,0.003763452,0.004811186,0.002076496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001853199,"about_ca_system_score_gemma":0.001487796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001877669,"about_ca_topic_score_gemma":0.00177485,"domain_scores_codex":[0.840991,0.1268132,0.009834121,0.007495538,0.01326187,0.001604211],"domain_scores_gemma":[0.658711,0.270904,0.02336557,0.0339642,0.01180533,0.001249809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.03815502,0.001026881,0.1622104,0.01892323,0.1145764,0.001110203,0.002769428,0.01601865,0.003146489,0.194222,0.04050146,0.4073398],"study_design_scores_gemma":[0.007179533,0.0112571,0.3442352,0.002970538,0.05312832,0.003073855,0.001351738,0.03046815,0.01434052,0.4016545,0.1293298,0.001010784],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.348903,0.04800359,0.4134516,0.006984215,0.007193699,0.007062477,0.07141212,0.0009060659,0.09608321],"genre_scores_gemma":[0.9158445,0.002023184,0.0590383,0.002015691,0.0009879383,0.003468021,0.01060363,0.000302699,0.005716098],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.07638894,"threshold_uncertainty_score":0.4039882,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2488281113","doi":"10.5639/gabij.2016.0502.016","title":"Biosimilars patent litigation in Canada and Japan: a comparative strategic overview and EU and US update","year":2016,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Amgen Canada","keywords":"Biosimilar; Business; International trade; Law and economics; Economics; Medicine; Internal medicine","authors":[{"name":"Brian J Malkin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1216381562871027,"gpt":0.2871633744820115,"spread":0.1655252181949087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0085889,0.0006006319,0.0009220357,0.01627949,0.004746349,0.009873789,0.001745087,0.004163987,0.005468463],"category_scores_gemma":[0.01640427,0.0005917024,0.001420613,0.03491773,0.004253228,0.003228776,0.002049781,0.003357113,0.000484936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08773772,"about_ca_system_score_gemma":0.1499521,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9213666,"about_ca_topic_score_gemma":0.9679961,"domain_scores_codex":[0.9889346,0.0007745121,0.0007888424,0.0006515524,0.006662798,0.002187772],"domain_scores_gemma":[0.9506458,0.01093741,0.006650083,0.0003892778,0.02748571,0.003891761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001537735,0.0003973237,0.1033995,0.007652712,0.0005569822,0.002746478,0.007217876,0.001201126,0.001022519,0.07559562,0.2516666,0.5470055],"study_design_scores_gemma":[0.0001960695,0.0003814538,0.3792393,0.009070789,0.001406406,0.002851523,0.01770066,0.000676572,0.001249668,0.002322355,0.5846066,0.0002986047],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.09248506,0.7112317,0.0008063257,0.0708055,0.001285454,0.0001952301,0.006383695,0.00009997025,0.1167071],"genre_scores_gemma":[0.38588,0.5642673,0.001836422,0.03030129,0.001049087,0.00007942432,0.004113032,0.00009281367,0.0123805],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.08773772,"threshold_uncertainty_score":0.6365846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2547846819","doi":"10.5639/gabij.2016.0503.032","title":"Are the perspectives regarding the use of biosimilars in the setting of haematology and blood and marrow transplant changing?","year":2016,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Hematology; Medicine; Internal medicine; Intensive care medicine","authors":[{"name":"Cherie Severson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06043340861617394,"gpt":0.2741436092015638,"spread":0.2137102005853899,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03726026,0.0004735439,0.001085178,0.001325158,0.003031153,0.01148698,0.002988818,0.01740114,0.02249198],"category_scores_gemma":[0.1318112,0.0004086054,0.001756203,0.002076293,0.007928106,0.01143532,0.003707167,0.0134216,0.002535988],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007876244,"about_ca_system_score_gemma":0.02758125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01567103,"about_ca_topic_score_gemma":0.0303906,"domain_scores_codex":[0.977117,0.01180352,0.002379594,0.001470469,0.004948218,0.002281186],"domain_scores_gemma":[0.8246191,0.08502306,0.02056139,0.002281364,0.03987524,0.02763994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0009821996,0.0004757545,0.02006704,0.003368546,0.0002744238,0.002335745,0.003300454,0.001477096,0.001232313,0.07117858,0.5374986,0.3578093],"study_design_scores_gemma":[0.0003332367,0.001031219,0.02896516,0.01729119,0.0003583546,0.004999394,0.0291575,0.001266425,0.0007675968,0.1324526,0.7828816,0.0004957003],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.002111264,0.01845716,0.000392619,0.972524,0.002572594,0.000006730565,0.0000867813,0.0000128095,0.003836118],"genre_scores_gemma":[0.086086,0.09668904,0.003807172,0.7866355,0.02452304,0.0000609979,0.000277196,0.000055868,0.001865284],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03726026,"threshold_uncertainty_score":0.1970534,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400830732","doi":"10.5639/gabij.2022.1103.018","title":"Key factors for successful uptake of biosimilars: Europe and the US","year":2022,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Key (lock); Business; Medicine; Computer science; Computer security; Internal medicine","authors":[{"name":"Michael S Reilly","is_ca":false},{"name":"Philip J. Schneider","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03940386486012425,"gpt":0.2793923534529661,"spread":0.2399884885928418,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01455401,0.0001767665,0.0002647116,0.001398399,0.001367088,0.004612636,0.000597844,0.002396889,0.01275749],"category_scores_gemma":[0.04025187,0.0001880854,0.0003945199,0.002238115,0.00175589,0.003460407,0.002542371,0.00235349,0.0009798253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003534749,"about_ca_system_score_gemma":0.006957606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0126773,"about_ca_topic_score_gemma":0.009963099,"domain_scores_codex":[0.9879958,0.004155761,0.001215817,0.0008757394,0.003811988,0.001944874],"domain_scores_gemma":[0.9525378,0.0237162,0.007592725,0.0009640972,0.008828498,0.006360688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001357445,0.0007515126,0.5066508,0.001353681,0.0002067627,0.002315426,0.01611232,0.001216492,0.00469802,0.03812663,0.05690249,0.3703085],"study_design_scores_gemma":[0.0001408279,0.0009126651,0.6520777,0.00324587,0.0001909336,0.004206588,0.03097465,0.001350635,0.006995177,0.0115425,0.2881927,0.0001697051],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7069647,0.01625986,0.002804598,0.1043705,0.0006591043,0.0002013722,0.0004994352,0.0001416825,0.1680987],"genre_scores_gemma":[0.9857144,0.002233342,0.001207833,0.00818968,0.0001765187,0.00002807839,0.0001371304,0.00005103975,0.002262021],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01455401,"threshold_uncertainty_score":0.07696986,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3216742648","doi":"10.5639/gabij.2021.1003.016","title":"A critical review of substitution policy for biosimilars in Canada","year":2021,"lang":"en","type":"review","venue":"Generics and Biosimilars Initiative Journal","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Competition (biology); Business; Market competition; Public economics; Marketing; Medicine; Economics; Market economy","authors":[{"name":"Philip J. Schneider","is_ca":false},{"name":"Michael S Reilly","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2179399431878375,"gpt":0.3831076496905857,"spread":0.1651677065027482,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01004747,0.0009305852,0.003061989,0.008630879,0.001329849,0.003558128,0.002489397,0.002491881,0.004254906],"category_scores_gemma":[0.03257447,0.0007599048,0.00184632,0.01473812,0.001534447,0.001851607,0.0009110369,0.00298817,0.0005976933],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03320425,"about_ca_system_score_gemma":0.1025733,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4102519,"about_ca_topic_score_gemma":0.5250148,"domain_scores_codex":[0.9948265,0.0009660052,0.001020381,0.0003392589,0.002499615,0.0003482154],"domain_scores_gemma":[0.9700523,0.01322278,0.002781561,0.0004240959,0.012849,0.0006701596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003064885,0.00005647919,0.0008003382,0.203462,0.0009446386,0.0002612787,0.0003968776,0.001256893,0.0003572108,0.01869692,0.1303485,0.6431123],"study_design_scores_gemma":[0.00006011648,0.00006958016,0.002854338,0.1856074,0.001356754,0.0003087146,0.0002011147,0.0001779761,0.0002464355,0.001773904,0.8072897,0.00005383079],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001111152,0.9967667,0.00005292378,0.001775837,0.0002719065,0.00002111492,0.0001257528,0.000003433973,0.0008712219],"genre_scores_gemma":[0.002283564,0.9962179,0.0001928496,0.0009249277,0.0001072228,0.00001989705,0.00007796453,0.00000326832,0.0001723001],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9667957,"threshold_uncertainty_score":0.815728,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401034735","doi":"10.5639/gabij.2023.1201.006","title":"Non-medical switching of biologicals/biosimilars: Canada, Europe and the US – a webinar report","year":2023,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Medicine; Internal medicine","authors":[{"name":"Michael S Reilly","is_ca":false},{"name":"Gail Attara","is_ca":false},{"name":"Ralph D McKibbin","is_ca":false},{"name":"Philip J. Schneider","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02511126627845165,"gpt":0.2745983956887593,"spread":0.2494871294103076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01028532,0.0004384742,0.0002336548,0.002036151,0.00340589,0.003902206,0.0008976049,0.001717553,0.01522951],"category_scores_gemma":[0.0148108,0.000301557,0.0004563252,0.002893861,0.000950691,0.001547555,0.001916532,0.002371089,0.001547548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03089579,"about_ca_system_score_gemma":0.09490718,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8560333,"about_ca_topic_score_gemma":0.8854425,"domain_scores_codex":[0.9924819,0.0009386172,0.0004144716,0.000285344,0.004236427,0.001643206],"domain_scores_gemma":[0.9713333,0.004311473,0.001060976,0.000280772,0.01841926,0.004594194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006108182,0.0008351606,0.03669702,0.001931137,0.00005840015,0.001739901,0.01102125,0.0008905143,0.001702429,0.005183709,0.6591002,0.2802296],"study_design_scores_gemma":[0.00008705141,0.0002085461,0.1068456,0.00175537,0.00004335963,0.0006181066,0.01875624,0.0009055874,0.001784341,0.0005776201,0.8683072,0.0001108548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.2923169,0.03332376,0.004809705,0.1870707,0.004773336,0.00386001,0.02803398,0.001379115,0.4444326],"genre_scores_gemma":[0.7882318,0.03199214,0.006464812,0.04435889,0.001122197,0.0007927991,0.01922019,0.0004357483,0.1073813],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1439667,"threshold_uncertainty_score":0.289629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3110075982","doi":"10.5639/gabij.2020.0903.022","title":"3rd Colombian educational workshop on regulatory assessment of biosimilars 2019 – Report","year":2020,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Pharmacovigilance; Workgroup; Medicine; Quality (philosophy); Health professionals; Political science; Medical education; Health care; Pharmacology; Adverse effect; Computer science; Law","authors":[{"name":"John-Joseph Borg","is_ca":false},{"name":"Yolanda Elias Gramajo","is_ca":false},{"name":"Andrea Laslop","is_ca":false},{"name":"Robin Thorpe","is_ca":false},{"name":"Wang Jian","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05838303705914417,"gpt":0.3401759876671234,"spread":0.2817929506079792,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009504086,0.00139556,0.0004316402,0.001229811,0.002541399,0.006160981,0.001460432,0.004649667,0.05045625],"category_scores_gemma":[0.01138852,0.0004426502,0.0007131976,0.0005602709,0.001380353,0.002227003,0.005083214,0.005827519,0.01162772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0108239,"about_ca_system_score_gemma":0.01609252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02052276,"about_ca_topic_score_gemma":0.03685457,"domain_scores_codex":[0.9933349,0.002461097,0.0003702796,0.0005662901,0.001847953,0.00141945],"domain_scores_gemma":[0.9904189,0.001854719,0.0006991134,0.0002815956,0.004090828,0.002654977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001917977,0.00013083,0.000784868,0.0007892854,0.00001318531,0.000637137,0.002915967,0.0003694108,0.002244424,0.003546817,0.9428591,0.04551724],"study_design_scores_gemma":[0.00001034288,0.00001744503,0.001177607,0.0004391499,0.000004230055,0.00008772635,0.001161006,0.0000905047,0.0005322431,0.0004772944,0.995983,0.00001941288],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.02272537,0.03676469,0.01158832,0.4556927,0.1244255,0.002278447,0.00785776,0.00149295,0.3371743],"genre_scores_gemma":[0.2785938,0.02551673,0.02178075,0.1143443,0.02594274,0.002446642,0.01013317,0.001448557,0.5197933],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.05045625,"threshold_uncertainty_score":0.168793,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401026462","doi":"10.5639/gabij.2023.1202.008","title":"Canadian prescribers’ attitudes and perceptions about ophthalmic biosimilars","year":2023,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Perception; Medicine; Psychology; Internal medicine; Neuroscience","authors":[{"name":"Michael S Reilly","is_ca":false},{"name":"Jane Barratt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.039198613817649,"gpt":0.3057897446700765,"spread":0.2665911308524275,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006560333,0.000160771,0.000343587,0.001089924,0.005242155,0.003258963,0.00082242,0.001606918,0.007200493],"category_scores_gemma":[0.02633126,0.0003523456,0.0005034611,0.001887782,0.002558321,0.001169655,0.001197521,0.001968075,0.0004104081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01992849,"about_ca_system_score_gemma":0.03243217,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.907632,"about_ca_topic_score_gemma":0.8799736,"domain_scores_codex":[0.9909407,0.001352224,0.0004539347,0.0004246275,0.005614914,0.00121358],"domain_scores_gemma":[0.9695509,0.006990295,0.006806552,0.0005173317,0.008308712,0.007826153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000509818,0.000433406,0.6999945,0.0007211952,0.0001192484,0.001180697,0.2230349,0.0003789648,0.002020734,0.002025586,0.02341174,0.04616922],"study_design_scores_gemma":[0.0001220296,0.0004522772,0.740389,0.0008838706,0.00008388049,0.0008683055,0.2082699,0.0006635129,0.0004413593,0.0003145697,0.0473516,0.0001595591],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9661863,0.001613326,0.0001219193,0.01452239,0.00008011262,0.0000686409,0.0003722573,0.00001585869,0.01701914],"genre_scores_gemma":[0.9933709,0.001477649,0.0001927601,0.003311376,0.0000287603,0.00001440883,0.0001413737,0.000006835131,0.001455859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09236801,"threshold_uncertainty_score":0.1858239,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3047360337","doi":"10.5639/gabij.2020.0901.005","title":"It is time to change US trade policy to foster access to medicines","year":2020,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Negotiation; Biosimilar; Balance (ability); Business; Access to medicines; Sustainability; International trade; International economics; Economics; Economic growth; Political science; Medicine; Developing country; Law","authors":[{"name":"María Fabiana Jorge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2419709964383773,"gpt":0.3549841684586827,"spread":0.1130131720203054,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02254859,0.001069277,0.001766738,0.001711052,0.005333559,0.01878697,0.003756166,0.03305809,0.02978638],"category_scores_gemma":[0.08146176,0.0006828575,0.002287192,0.002036967,0.007798539,0.01571953,0.005704384,0.03561053,0.01490137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007359581,"about_ca_system_score_gemma":0.03682892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01308589,"about_ca_topic_score_gemma":0.01981363,"domain_scores_codex":[0.9786645,0.005639034,0.001445752,0.001337346,0.008201405,0.004711985],"domain_scores_gemma":[0.9215881,0.01846859,0.006339683,0.003956392,0.02330332,0.02634389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000157871,0.0003391209,0.0005567349,0.0002582429,0.00006425525,0.0002224654,0.0003216609,0.0004141492,0.0004597798,0.0602936,0.8907071,0.04620515],"study_design_scores_gemma":[0.00007510334,0.00009724546,0.0009172572,0.0006476555,0.00003100948,0.0001083456,0.001205278,0.0001944943,0.0002348617,0.05853635,0.9378926,0.00005980889],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0003872887,0.002892733,0.0005946548,0.9783863,0.01350532,0.000009555081,0.00006751157,0.0001215348,0.004035052],"genre_scores_gemma":[0.008728961,0.003160009,0.003447163,0.972964,0.005572614,0.00003859041,0.0001209735,0.00009338662,0.005874311],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.03305809,"threshold_uncertainty_score":0.1192498,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4401026458","doi":"10.5639/gabij.2023.1202.007","title":"Extrapolation requires reading between the lines","year":2023,"lang":"en","type":"article","venue":"Generics and Biosimilars Initiative Journal","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Extrapolation; Reading (process); Computer science; Mathematics; Statistics; Philosophy; Linguistics","authors":[{"name":"Philip D Walson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05397317481298376,"gpt":0.3021157404149194,"spread":0.2481425656019356,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04628576,0.001602061,0.001653135,0.005469778,0.003525343,0.01242773,0.003078485,0.007010275,0.05596995],"category_scores_gemma":[0.3632632,0.001211147,0.002146637,0.003648823,0.007141775,0.01635007,0.006058702,0.01416278,0.0552415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002931783,"about_ca_system_score_gemma":0.006062913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003240902,"about_ca_topic_score_gemma":0.002395774,"domain_scores_codex":[0.9572868,0.01608217,0.007408324,0.003563839,0.01492856,0.0007303682],"domain_scores_gemma":[0.5665428,0.2746386,0.01182782,0.04426838,0.0994664,0.003255987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002718825,0.00007245142,0.0006597177,0.001400581,0.00009391706,0.000462079,0.0022511,0.0002890532,0.0006916038,0.08520597,0.7640831,0.1445185],"study_design_scores_gemma":[0.00003214956,0.00004802602,0.0003749896,0.001384418,0.00003919751,0.0001658976,0.0008943141,0.0002777974,0.0006038253,0.06406525,0.9320617,0.00005231434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"empirical","genre_scores_codex":[0.002530715,0.01056012,0.07045358,0.3244781,0.3915087,0.0007375209,0.002941357,0.002933723,0.1938562],"genre_scores_gemma":[0.06655894,0.02458099,0.1257339,0.3900997,0.1921703,0.002310831,0.005026052,0.006903451,0.1866158],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05596995,"threshold_uncertainty_score":0.2447854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}